Inotrem Receives Approval to Expand Nangibotide Clinical Trial in Critically Ill COVID-19 Patients ...

Retrieved on: 2021-07-12 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

Inotrem Receives Approval to Expand Nangibotide Clinical Trial in Critically Ill COVID-19 Patients .... View article details on hiswai:

Excerpt

Inotrem S.A., a biotechnology company specializing in the development of immunotherapies targeting the TREM-1 pathway, announces that it has ...

Article found on: www.valdostadailytimes.com